Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash at Skyway Road and Notre Dame Boulevard


Woman Hits Retaining Wall in Fatal Chico Accident

Chico, CA (March 26, 2020) – A woman was killed in a solo-vehicle crash in Chico. The fatal accident occurred on the morning of March 26 at Skyway Road and Notre Dame Boulevard.

A woman was driving a Honda Accord eastbound when the vehicle drifted to the left. The woman slammed into a retaining wall in the area. She died at the accident scene. The roads were closed for several hours.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Chico

#95928


May 18, 2020

1 Injured in Crash on Highway 246 at Mission Gate Road

2 Cars Involved in Lompoc Accident...


January 3, 2020

Todd James Kern Killed in Crash on Highway 50 Near E. Bidwell Street

Pickup Truck Hits Tree in Fatal Folsom Accident...


February 17, 2020

1 Killed in Wrong-Way Crash on 210 Freeway Near Huntington Drive

2 Cars Collide Head-on in Fatal Monrovia Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.